Better Outcomes With Early HETs in Pediatric-Onset MS : vima

Early initiation of HET in pediatric-onset MS was linked to slower progression to disability compared to treatment with low-efficacy therapy or no treatment.

Related Keywords

Toronto , Ontario , Canada , Melbourne , Victoria , Australia , Italy , Italian , Sifat Sharman , E Ann Yeh , Department Of Medicine , University Of Melbourne , European Medicines Agency , Demyelinating Disorders Program , University Of Toronto , Drug Administration , Lancet Child , Italian Multiple Sclerosis , Related Disorders Register , Expanded Disability Status Scale , Pediatric Multiple Sclerosis , Multiple Sclerosis Ms , S Multiple Sclerosis , Disability , Children , Child , Childhood , Ediatrics , Kids , Biologic Therapy , Iologics , Transplantation Of Stem Cells , Ransplantation Of Hematopoietic Stem Cells , Hematopoietic Stem Cell Transplant , Stem Cell Transplantation , Stem Cell Therapy , Tem Cell Haematopoietic Stem Transplant ,